Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.

HematoOncology

Anagrelide AOP

Anagrelide AOP is used to reduce the number of platelets in patients with essential thrombocythaemia.

Drug Facts
Active Ingredient
Anagrelide